Skip to main content
PMC home page
Gut logoLink to Gut
. 1989 Apr;30(4):449–454. doi: 10.1136/gut.30.4.449

Rebound nocturnal hypersecretion after four weeks treatment with an H2 receptor antagonist.

G M Fullarton 1, G McLauchlan 1, A Macdonald 1, G P Crean 1, K E McColl 1
PMCID: PMC1434043  PMID: 2565860

Abstract

Daytime intragastric pH, fasting and meal stimulated serum gastrin and nocturnal acid output were studied in eight male duodenal ulcer patients before, during and two days after completing nizatidine 300 mg nocte (20:00 h) for four weeks. Median nocturnal acid output (mmol/10 h) decreased during treatment to 11.6 (range 0.4-26.7) compared with pretreatment value of 39.4 (9.8-91.2); median acid inhibition 77% (p less than 0.01) which was strongest between 24:00 and 04:00 h. Two days after discontinuing treatment, nocturnal acid output increased to 74.1 (11-181). Compared with the pretreatment value this represents median rebound hypersecretion of 77% (p less than 0.05), caused by increased H+ concentration and volume of secretion. Overall median daytime intragastric pH (09:00-21:00 h) was unchanged on the final day of treatment and two days after completing therapy, compared with the pretreatment values. Fasting serum gastrin measured between 09:30 and 10:00 h and the integrated gastrin response to an OXO breakfast taken out at 10:00 h were also similar during and after treatment, compared with pretreatment values. The rebound nocturnal hypersecretion may be relevant to the high ulcer relapse rates after stopping H2 receptor antagonists.

Full text

PDF
450

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aadland E., Berstad A. Parietal and chief cell sensitivity to histamine and pentagastrin stimulation before and after cimetidine treatment in healthy subjects. Scand J Gastroenterol. 1979;14(8):933–938. [PubMed] [Google Scholar]
  2. Binder H. J., Cocco A., Crossley R. J., Finkelstein W., Font R., Friedman G., Groarke J., Hughes W., Johnson A. F., McGuigan J. E. Cimetidine in the treatment of duodenal ulcer: a multicenter double blind study. Gastroenterology. 1978 Feb;74(2 Pt 2):380–388. [PubMed] [Google Scholar]
  3. Bodemar G., Walan A. Maintenance treatment of recurrent peptic ulcer by cimetidine. Lancet. 1978 Feb 25;1(8061):403–407. doi: 10.1016/s0140-6736(78)91200-x. [DOI] [PubMed] [Google Scholar]
  4. Callaghan J. T., Bergstrom R. F., Rubin A., Chernish S., Crabtree R., Knadler M. P., Obermeyer B., Offen W. W., Schneck D. W., Aronoff G. A pharmacokinetic profile of nizatidine in man. Scand J Gastroenterol Suppl. 1987;136:9–17. doi: 10.3109/00365528709094480. [DOI] [PubMed] [Google Scholar]
  5. Cerulli M. A., Cloud M. L., Offen W. W., Chernish S. M., Matsumoto C. Nizatidine as maintenance therapy of duodenal ulcer disease in remission. Scand J Gastroenterol Suppl. 1987;136:79–83. doi: 10.3109/00365528709094490. [DOI] [PubMed] [Google Scholar]
  6. Dammann H. G., Gottlieb W. R., Walter T. A., Müller P., Simon B., Keohane P. The 24-hour acid suppression profile of nizatidine. Scand J Gastroenterol Suppl. 1987;136:56–60. doi: 10.3109/00365528709094487. [DOI] [PubMed] [Google Scholar]
  7. Dammann H. G., Müller P., Simon B. Inhibition of nocturnal acid secretion by H2-receptor-antagonist SKF 93479. Lancet. 1982 Jan 23;1(8265):224–224. doi: 10.1016/s0140-6736(82)90788-7. [DOI] [PubMed] [Google Scholar]
  8. Dobrilla G., Vallaperta P., Amplatz S. Influence of ulcer healing agents on ulcer relapse after discontinuation of acute treatment: a pooled estimate of controlled clinical trials. Gut. 1988 Feb;29(2):181–187. doi: 10.1136/gut.29.2.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ekman L., Hansson E., Havu N., Carlsson E., Lundberg C. Toxicological studies on omeprazole. Scand J Gastroenterol Suppl. 1985;108:53–69. [PubMed] [Google Scholar]
  10. Frislid K., Aadland E., Berstad A. Augmented postprandial gastric acid secretion due to exposure to ranitidine in healthy subjects. Scand J Gastroenterol. 1986 Jan;21(1):119–122. doi: 10.3109/00365528609034634. [DOI] [PubMed] [Google Scholar]
  11. Gledhill T., Howard O. M., Buck M., Paul A., Hunt R. H. Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer. Gut. 1983 Oct;24(10):904–908. doi: 10.1136/gut.24.10.904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Halter F., Inauen W., Eigenmann F., Varga L., Koelz H. R. Effect of acid inhibition on the growth of parietal cells. Scand J Gastroenterol Suppl. 1986;125:9–13. doi: 10.3109/00365528609093812. [DOI] [PubMed] [Google Scholar]
  13. Jones D. B., Howden C. W., Burget D. W., Silletti C., Hunt R. H. Alteration of H2 receptor sensitivity in duodenal ulcer patients after maintenance treatment with an H2 receptor antagonist. Gut. 1988 Jul;29(7):890–893. doi: 10.1136/gut.29.7.890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Larsson H., Carlsson E., Mattsson H., Lundell L., Sundler F., Sundell G., Wallmark B., Watanabe T., Håkanson R. Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology. 1986 Feb;90(2):391–399. doi: 10.1016/0016-5085(86)90938-8. [DOI] [PubMed] [Google Scholar]
  15. Longstreth G. F., Go V. L., Malagelada J. R. Cimetidine suppression of nocturnal gastric secretion in active duodenal ulcer. N Engl J Med. 1976 Apr 8;294(15):801–804. doi: 10.1056/NEJM197604082941502. [DOI] [PubMed] [Google Scholar]
  16. Martin D. F., Hollanders D., May S. J., Ravenscroft M. M., Tweedle D. E., Miller J. P. Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate. Lancet. 1981 Jan 3;1(8210):7–10. doi: 10.1016/s0140-6736(81)90114-8. [DOI] [PubMed] [Google Scholar]
  17. Miller J. P., Faragher E. B. Relapse of duodenal ulcer: does it matter which drug is used in initial treatment? Br Med J (Clin Res Ed) 1986 Nov 1;293(6555):1117–1118. doi: 10.1136/bmj.293.6555.1117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mohammed R., Holden R. J., Hearns J. B., McKibben B. M., Buchanan K. D., Crean G. P. Effects of eight weeks' continuous treatment with oral ranitidine and cimetidine on gastric acid secretion, pepsin secretion, and fasting serum gastrin. Gut. 1983 Jan;24(1):61–66. doi: 10.1136/gut.24.1.61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Penston J., Wormsley K. G. Achlorhydria: hypergastrinaemia: carcinoids--a flawed hypothesis? Gut. 1987 Apr;28(4):488–505. doi: 10.1136/gut.28.4.488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Reed P. I., Smith P. L., Haines K., House F. R., Walters C. L. Gastric juice N-nitrosamines in health and gastroduodenal disease. Lancet. 1981 Sep 12;2(8246):550–552. doi: 10.1016/s0140-6736(81)90939-9. [DOI] [PubMed] [Google Scholar]
  21. Richards D. A. Comparative pharmacodynamics and pharmacokinetics of cimetidine and ranitidine. J Clin Gastroenterol. 1983;5 (Suppl 1):81–90. doi: 10.1097/00004836-198312001-00008. [DOI] [PubMed] [Google Scholar]
  22. Schlag P., Böckler R., Peter M. Nitrite and nitrosamines in gastric juice: risk factors for gastric cancer? Scand J Gastroenterol. 1982 Jan;17(1):145–150. doi: 10.3109/00365528209181060. [DOI] [PubMed] [Google Scholar]
  23. Simon B., Cremer M., Dammann H. G., Hentschel E., Keohane P. P., Mulder H., Müller P., Sarles H. 300 mg nizatidine at night versus 300 mg ranitidine at night in patients with duodenal ulcer. A multicentre trial in Europe. Scand J Gastroenterol Suppl. 1987;136:61–70. doi: 10.3109/00365528709094488. [DOI] [PubMed] [Google Scholar]
  24. Walt R. P., Male P. J., Rawlings J., Hunt R. H., Milton-Thompson G. J., Misiewicz J. J. Comparison of the effects of ranitidine, cimetidine and placebo on the 24 hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer. Gut. 1981 Jan;22(1):49–54. doi: 10.1136/gut.22.1.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Witzel L., Halter F., Olah A. J., Häcki W. H. Effects of prolonged metiamide medication on the fundic mucosa. A secretory and histomorphometric study in the rat. Gastroenterology. 1977 Oct;73(4 Pt 1):797–803. [PubMed] [Google Scholar]
  26. Yeh K. C., Kwan K. C. A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximation. J Pharmacokinet Biopharm. 1978 Feb;6(1):79–98. doi: 10.1007/BF01066064. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES